Delphi advisor to Bentley Endovascular Group AB (publ) in connection with a pre-IPO transaction

Delphi has advised Bentley Endovascular Group AB (publ) in connection with a pre-IPO transaction where Keensight Capital alongside A.P. Moller Holding and Swedish family office Bonit Capital’s acquired a minority stake in the company from current shareholders.

The medical technology holding company Bentley Endovascular Group AB, headquartered in Stockholm, Sweden, controls its German subsidiary Bentley InnoMed GmbH, as well as Qmedics AG, based in Switzerland. Founded in 2009 by Lars Sunnanväder and Miko Obradovic, Bentley InnoMed GmbH is based in the medical technology stronghold of Hechingen in Baden-Wurttemberg, Germany. The company develops, manufactures, and markets implants and catheters for the endovascular treatment of peripheral vascular and aortic diseases.

Delphi’s team primarily consisted of Mats Dahlberg and Alexander Nilsson.